HCT, hematopoietic cell transplantation; NHL, non-Hodgkin's lymphoma; AML, acute myelogenous leukemia; HD, Hodgkin's disease; RIC, reduced-intensity conditioning; MDS, myelodysplastic syndrome; ALL, acute lymphoblastic leukemia; CML, chronic myelogenous leukemia; AL, acute leukemia; MM, multiple myeloma; MPD, myelodysplastic syndrome; PNH, paroxysmal nocturnal hemoglobinuria; Cy, cyclophosphamide; XRT, radiotherapy; ATG, anti-thymocyte globulin; Bu, busulfan; Flu, fludarabine; BM, bone marrow cells; TCD, T-cell depletion; G-PB, growth factor-mobilized peripheral blood mononuclear cells; CSA, cyclosporine; MTX, methotrexate; MPD, methylprednisolone; MMF, mycophenolate mofetil; aGVHD, acute graft-versus-host disease; gr, grade; cGVHD, chronic graft-versus-host disease; CR, complete remission; PR, partial remission; MC, mixed chimerism; TRM, transplantation-related mortality; NRM, non-relapse mortality ; UD, unrelated donor
